76 related articles for article (PubMed ID: 22913774)
1. Exendin-4 protects murine pancreatic β-cells from free fatty acid-induced apoptosis through PI-3K signaling.
Liu L; Wang Y; Wang L; Lin Y; Liu X; Liu X; Liu L
Endocr Res; 2013; 38(1):40-7. PubMed ID: 22913774
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
3. Exendin-4 protects murine pancreatic β-cells from dexamethasone-induced apoptosis through PKA and PI-3K signaling.
Wang LX; Wang YP; Chen Z; Liu XY; Liu XH; Liu L; Chen WJ; Liu LB
Diabetes Res Clin Pract; 2010 Dec; 90(3):297-304. PubMed ID: 20889222
[TBL] [Abstract][Full Text] [Related]
4. Enhanced protection against cytokine- and fatty acid-induced apoptosis in pancreatic beta cells by combined treatment with glucagon-like peptide-1 receptor agonists and insulin analogues.
Tews D; Werner U; Eckel J
Horm Metab Res; 2008 Mar; 40(3):172-80. PubMed ID: 18348079
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis.
Fan R; Li X; Gu X; Chan JC; Xu G
Diabetes Obes Metab; 2010 Sep; 12(9):815-24. PubMed ID: 20649634
[TBL] [Abstract][Full Text] [Related]
6. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
7. Role of ERp46 in β-cell lipoapoptosis through endoplasmic reticulum stress pathway as well as the protective effect of exendin-4.
Chen DL; Xiang JN; Yang LY
Biochem Biophys Res Commun; 2012 Sep; 426(3):324-9. PubMed ID: 22935416
[TBL] [Abstract][Full Text] [Related]
8. Effect of PANDER in βTC6-cell lipoapoptosis and the protective role of exendin-4.
Xiang JN; Chen DL; Yang LY
Biochem Biophys Res Commun; 2012 May; 421(4):701-6. PubMed ID: 22542939
[TBL] [Abstract][Full Text] [Related]
9. Exendin-4, a glucagon-like peptide-1 receptor agonist, suppresses pancreatic β-cell destruction induced by encephalomyocarditis virus.
Sano H; Terasaki J; Mishiba Y; Imagawa A; Hanafusa T
Biochem Biophys Res Commun; 2011 Jan; 404(3):756-61. PubMed ID: 21144822
[TBL] [Abstract][Full Text] [Related]
10. Exendin-4 protects beta-cells from interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway.
Ferdaoussi M; Abdelli S; Yang JY; Cornu M; Niederhauser G; Favre D; Widmann C; Regazzi R; Thorens B; Waeber G; Abderrahmani A
Diabetes; 2008 May; 57(5):1205-15. PubMed ID: 18252896
[TBL] [Abstract][Full Text] [Related]
11. Exendin-4 protects HUVECs from t-BHP-induced apoptosis via PI3K/Akt-Bcl-2-caspase-3 signaling.
Wang L; Tang L; Wang Y; Wang L; Liu X; Liu X; Chen Z; Liu L
Endocr Res; 2016 Aug; 41(3):229-35. PubMed ID: 27030608
[TBL] [Abstract][Full Text] [Related]
12. Exendin-4 inhibits glucolipotoxic ER stress in pancreatic β cells via regulation of SREBP1c and C/EBPβ transcription factors.
Oh YS; Lee YJ; Kang Y; Han J; Lim OK; Jun HS
J Endocrinol; 2013 Mar; 216(3):343-52. PubMed ID: 23257266
[TBL] [Abstract][Full Text] [Related]
13. Anti-apoptotic action of exendin-4 in INS-1 beta cells: comparative protein pattern analysis of isolated mitochondria.
Tews D; Lehr S; Hartwig S; Osmers A; Paslack W; Eckel J
Horm Metab Res; 2009 Apr; 41(4):294-301. PubMed ID: 19085810
[TBL] [Abstract][Full Text] [Related]
14. The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro.
Bregenholt S; Møldrup A; Blume N; Karlsen AE; Nissen Friedrichsen B; Tornhave D; Knudsen LB; Petersen JS
Biochem Biophys Res Commun; 2005 May; 330(2):577-84. PubMed ID: 15796922
[TBL] [Abstract][Full Text] [Related]
15. Protection of pancreatic beta-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies.
Tsunekawa S; Yamamoto N; Tsukamoto K; Itoh Y; Kaneko Y; Kimura T; Ariyoshi Y; Miura Y; Oiso Y; Niki I
J Endocrinol; 2007 Apr; 193(1):65-74. PubMed ID: 17400804
[TBL] [Abstract][Full Text] [Related]
16. [Effects of glucagon-like peptide-1 on the free fatty acid-induced expression of pancreatic derived factor in cultured β-TC3 cell line].
Chen S; Cao XP; Xiao HP; Li YB
Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1413-6. PubMed ID: 21756815
[TBL] [Abstract][Full Text] [Related]
17. Direct apoptotic effects of free fatty acids on human endothelial cells.
Piro S; Spampinato D; Spadaro L; Oliveri CE; Purrello F; Rabuazzo AM
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):96-104. PubMed ID: 17560770
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B.
Li L; El-Kholy W; Rhodes CJ; Brubaker PL
Diabetologia; 2005 Jul; 48(7):1339-49. PubMed ID: 15902400
[TBL] [Abstract][Full Text] [Related]
19. Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 Analogue.
Baden MY; Fukui K; Hosokawa Y; Iwahashi H; Imagawa A; Shimomura I
PLoS One; 2015; 10(12):e0144606. PubMed ID: 26659307
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis.
Marzioni M; Alpini G; Saccomanno S; Candelaresi C; Venter J; Rychlicki C; Fava G; Francis H; Trozzi L; Glaser S; Benedetti A
Gastroenterology; 2007 Jul; 133(1):244-55. PubMed ID: 17631146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
